These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24692001)

  • 1. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
    Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
    Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for cognitive decline in patients with confluent white matter hyperintensities.
    Mok V; Xiong Y; Wong KK; Wong A; Schmidt R; Chu WW; Hu X; Lung Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S96-S103. PubMed ID: 22651941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confluent White Matter in Progression to Alzheimer Dementia.
    Heng LC; Lim SH; Foo H; Kandiah N
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):8-13. PubMed ID: 33009038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
    Hong H; Tozer DJ; Markus HS
    Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of acute infarcts to cerebral small vessel disease progression.
    Ter Telgte A; Wiegertjes K; Gesierich B; Marques JP; Huebner M; de Klerk JJ; Schreuder FHBM; Araque Caballero MA; Kuijf HJ; Norris DG; Klijn CJM; Dichgans M; Tuladhar AM; Duering M; de Leeuw FE
    Ann Neurol; 2019 Oct; 86(4):582-592. PubMed ID: 31340067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension.
    Jiménez-Balado J; Riba-Llena I; Abril O; Garde E; Penalba A; Ostos E; Maisterra O; Montaner J; Noviembre M; Mundet X; Ventura O; Pizarro J; Delgado P
    Hypertension; 2019 Feb; 73(2):342-349. PubMed ID: 30606062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.
    Zeestraten EA; Lawrence AJ; Lambert C; Benjamin P; Brookes RL; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Neurology; 2017 Oct; 89(18):1869-1876. PubMed ID: 28978655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study.
    Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D
    Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
    J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter integrity in small vessel disease is related to cognition.
    Tuladhar AM; van Norden AG; de Laat KF; Zwiers MP; van Dijk EJ; Norris DG; de Leeuw FE
    Neuroimage Clin; 2015; 7():518-24. PubMed ID: 25737960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.
    Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.